La Jolla Pharmaceutical Stock Fundamentals
| LJPCDelisted Stock | USD 6.22 0.00 0.00% |
La Jolla Pharmaceutical fundamentals help investors to digest information that contributes to La Jolla's financial success or failures. It also enables traders to predict the movement of LJPC Stock. The fundamental analysis module provides a way to measure La Jolla's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to La Jolla stock.
LJPC |
La Jolla Pharmaceutical Company Return On Asset Analysis
La Jolla's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current La Jolla Return On Asset | 1.64 |
Most of La Jolla's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, La Jolla Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, La Jolla Pharmaceutical has a Return On Asset of 1.64. This is 118.74% lower than that of the Healthcare sector and 106.95% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably lower than that of the firm.
La Jolla Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining La Jolla's current stock value. Our valuation model uses many indicators to compare La Jolla value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across La Jolla competition to find correlations between indicators driving La Jolla's intrinsic value. More Info.La Jolla Pharmaceutical is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies reporting about 30.15 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value La Jolla by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for La Jolla's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the La Jolla's earnings, one of the primary drivers of an investment's value.LJPC Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses La Jolla's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of La Jolla could also be used in its relative valuation, which is a method of valuing La Jolla by comparing valuation metrics of similar companies.La Jolla is currently under evaluation in return on asset category among related companies.
LJPC Fundamentals
| Return On Equity | 0.0544 | |||
| Return On Asset | 1.64 | |||
| Profit Margin | 10.08 % | |||
| Operating Margin | 4.68 % | |||
| Current Valuation | 242.85 M | |||
| Shares Outstanding | 27.52 M | |||
| Shares Owned By Insiders | 1.91 % | |||
| Shares Owned By Institutions | 71.79 % | |||
| Number Of Shares Shorted | 202.51 K | |||
| Price To Earning | 38.88 X | |||
| Price To Book | 30.11 X | |||
| Price To Sales | 3.29 X | |||
| Revenue | 52.01 M | |||
| Gross Profit | 63.08 M | |||
| EBITDA | 4.09 M | |||
| Net Income | 5.24 M | |||
| Cash And Equivalents | 44.56 M | |||
| Cash Per Share | 1.74 X | |||
| Total Debt | 124.8 M | |||
| Debt To Equity | 7.16 % | |||
| Current Ratio | 3.92 X | |||
| Book Value Per Share | (3.36) X | |||
| Cash Flow From Operations | 13.59 M | |||
| Short Ratio | 0.46 X | |||
| Earnings Per Share | (1.44) X | |||
| Price To Earnings To Growth | 11.72 X | |||
| Number Of Employees | 61 | |||
| Beta | 1.97 | |||
| Market Capitalization | 171.2 M | |||
| Total Asset | 89.52 M | |||
| Retained Earnings | (1.06 B) | |||
| Working Capital | 79.5 M | |||
| Current Asset | 86.74 M | |||
| Current Liabilities | 7.24 M | |||
| Z Score | -14.8 |
About La Jolla Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze La Jolla Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of La Jolla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of La Jolla Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. La Jolla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards La Jolla in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, La Jolla's short interest history, or implied volatility extrapolated from La Jolla options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in LJPC Stock
If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |